[Skip to Content]
Logo
  • About
    • Company/Facility
    • Executive Team and Board of Directors
    • Join Our Team
    • Contact Us
    • Supplier Terms & Conditions
  • Materials
    • Silicon Nitride
      • Industrial (STX-100)
      • Biomedical (FleX-SN)
  • Applications
    • Biomedical
    • Antipathogenic
  • Resources
    • Press/News
    • Events
    • Presentations
    • Publications
    • Case Studies
    • Research/Literature
    • Patents
    • Blog
    • References
  • Investors
  • OEM Solutions
    • Composite 3D Printing
Search
  • Contact Us
  • About
    • Company/Facility
    • Executive Team and Board of Directors
    • Join Our Team
    • Contact Us
    • Supplier Terms & Conditions
  • Materials
    • Silicon Nitride
      • Industrial (STX-100)
      • Biomedical (FleX-SN)
  • Applications
    • Biomedical
    • Antipathogenic
  • Resources
    • Press/News
    • Events
    • Presentations
    • Publications
    • Case Studies
    • Research/Literature
    • Patents
    • Blog
    • References
  • Investors
  • OEM Solutions
    • Composite 3D Printing
Search
  • Contact Us

Kevin Trask

November 17, 2025
Published by: Ranjan Chari

Stay Informed

* indicates required
Sintx
linkedin YouTube
  • Privacy
  • Disclaimer
  • Sitemap
  • FCOI Policy
© 2025 SINTX Technologies, Inc. All Rights Reserved. PDF Documents: Get Adobe® Reader®

SINTX Acquires   Learn more > HERE


SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Osteotomy Wedge System.

This FDA 510(k) clearance for our portfolio of silicon nitride osteotomy wedges marks the official entry into the foot and ankle reconstruction market. These next-generation implants blend cutting-edge biomaterials science with surgical precision and are designed to elevate standards in orthopedic procedures. Learn more HERE.